The most common side effects of GLP-1 medications include nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, dyspepsia, dizziness, abdominal distention, hypoglycemia in patients with type II diabetes
Yes, scheduling a consultation ensures we can provide you with personalized attention and recommendations
They are used with a reduced-calorie diet and increased physical activity to: reduce the risk of major cardiovascular events (death, heart attack, or stroke) in adults with known heart disease and either obesity or overweight
External resources FDA information on semaglutide medications for diabetes and obesity SURMOUNT-1 tirzepatide trial in the New England Journal of Medicine For those serious about optimizing their GLP-1 journey, SeekPeptides offers comprehensive protocols, dosing tools, tracking resources, and a community of thousands who have navigated these exact questions
Research has shown that estrogen deficiency (as in menopause) leads to decreased GLP-1 secretion, and estrogen replacement reverses this effect [3]
Eli Lilly cannot submit the NDA until enough Phase 3 data is available to demonstrate both efficacy and safety across the intended patient populations